• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类新生儿血清中补体因子9缺乏

Complement factor 9 deficiency in serum of human neonates.

作者信息

Lassiter H A, Watson S W, Seifring M L, Tanner J E

机构信息

Department of Pediatrics, University of Louisville School of Medicine, Kentucky.

出版信息

J Infect Dis. 1992 Jul;166(1):53-7. doi: 10.1093/infdis/166.1.53.

DOI:10.1093/infdis/166.1.53
PMID:1607708
Abstract

The serum concentration of complement factor C9 (C9) was 260 +/- 47 micrograms/ml (+/- SE) in 14 mothers and less than 42 micrograms/ml in each of their 14 neonates. During incubation for 60 min, 11 of 14 maternal sera and 3 of 14 neonatal sera reduced the survival of Escherichia coli O7w:K1:NM to less than 20% of the original inoculum (P less than .03). Eleven neonatal sera did not kill the bacteria. Supplemental C9 (60 micrograms/ml) enhanced the bactericidal capacity of 10 neonatal sera. 125I-labeled C9 was deposited onto E. coli by neonatal sera, but less efficiently than by pooled adult sera. Supplemental IgG enhanced 125I-labeled C9 deposition and potentiated the bactericidal activity of exogenous C9. Therefore, neonatal sera contained diminished concentrations of C9 and killed E. coli inefficiently. In neonatal sera, supplemental C9 was deposited onto E. coli and enhanced bactericidal activity. These effects of C9 were potentiated by supplemental IgG.

摘要

14名母亲血清中补体因子C9(C9)的浓度为260±47微克/毫升(±标准误),其14名新生儿血清中C9浓度均低于42微克/毫升。在孵育60分钟期间,14份母亲血清中有11份以及14份新生儿血清中有3份可将大肠杆菌O7w:K1:NM的存活率降至低于初始接种量的20%(P<0.03)。11份新生儿血清不能杀灭细菌。补充C9(60微克/毫升)可增强10份新生儿血清的杀菌能力。125I标记的C9可被新生儿血清沉积到大肠杆菌上,但效率低于混合成人血清。补充IgG可增强125I标记的C9沉积,并增强外源性C9的杀菌活性。因此,新生儿血清中C9浓度降低,杀灭大肠杆菌的效率低下。在新生儿血清中,补充的C9可沉积到大肠杆菌上并增强杀菌活性。C9的这些作用可被补充的IgG增强。

相似文献

1
Complement factor 9 deficiency in serum of human neonates.人类新生儿血清中补体因子9缺乏
J Infect Dis. 1992 Jul;166(1):53-7. doi: 10.1093/infdis/166.1.53.
2
Supplemental complement component C9 enhances the capacity of neonatal serum to kill multiple isolates of pathogenic Escherichia coli.补充补体成分C9可增强新生儿血清杀灭多种致病性大肠杆菌分离株的能力。
Pediatr Res. 1994 Apr;35(4 Pt 1):389-96.
3
Complement component C9 enhances the capacity of beta-lactam antibiotics to kill Escherichia coli in vitro and in vivo.
Am J Med Sci. 1998 May;315(5):307-13. doi: 10.1097/00000441-199805000-00004.
4
Inefficient bacteriolysis of Escherichia coli by serum from human neonates.
J Infect Dis. 1992 Feb;165(2):290-8. doi: 10.1093/infdis/165.2.290.
5
The administration of complement component C9 enhances the survival of neonatal rats with Escherichia coli sepsis.
Pediatr Res. 1997 Jul;42(1):128-36. doi: 10.1203/00006450-199707000-00020.
6
Immunologic regulation of E. coli K1 by serum from neonatal rats is enhanced following intraperitoneal administration of human IgG.新生大鼠血清对大肠杆菌K1的免疫调节在腹腔注射人免疫球蛋白后增强。
J Infect Dis. 1989 Mar;159(3):518-25. doi: 10.1093/infdis/159.3.518.
7
Bactericidal activity of C9-deficient human serum.C9缺陷型人血清的杀菌活性。
J Immunol. 1992 Feb 1;148(3):837-43.
8
Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.细菌对补体介导杀伤的抗性机制研究。V. IgG和F(ab')2通过替代补体途径介导对大肠杆菌O111B4的杀伤,而不增加C5b-9沉积。
J Immunol. 1983 Nov;131(5):2563-9.
9
The role of C9 in complement-mediated killing of Neisseria.C9在补体介导的奈瑟菌杀伤中的作用。
J Immunol. 1981 Dec;127(6):2386-90.
10
A high incidence of C9 deficiency among healthy blood donors in Osaka, Japan.日本大阪健康献血者中C9缺乏症的高发病率。
Int Immunol. 1989;1(1):85-9. doi: 10.1093/intimm/1.1.85.

引用本文的文献

1
Distinct protein patterns related to postnatal development in small for gestational age preterm infants.与小于胎龄早产儿出生后发育相关的独特蛋白质模式。
Pediatr Res. 2024 Aug 16. doi: 10.1038/s41390-024-03481-0.
2
Comparative Analysis of Global Gene Expression and Complement Components Levels in Umbilical Cord Blood from Preterm and Term Neonates: Implications for Significant Downregulation of Immune Response Pathways related to Prematurity.早产和足月新生儿脐血中基因表达和补体成分水平的比较分析:对与早产相关的免疫反应途径显著下调的意义。
Int J Med Sci. 2020 Jul 11;17(12):1840-1853. doi: 10.7150/ijms.46339. eCollection 2020.
3
Age-related variations in the bactericidal activity of human sera against .
人类血清对……的杀菌活性的年龄相关变化。 (注:原文中“against”后内容不完整)
Cent Eur J Immunol. 2018;43(1):18-25. doi: 10.5114/ceji.2018.74869. Epub 2018 Mar 30.
4
The role of inflammation in perinatal brain injury.炎症在围产期脑损伤中的作用。
Nat Rev Neurol. 2015 Apr;11(4):192-208. doi: 10.1038/nrneurol.2015.13. Epub 2015 Feb 17.
5
Mechanisms of perinatal arterial ischemic stroke.围产期动脉缺血性卒中的发病机制。
J Cereb Blood Flow Metab. 2014 Jun;34(6):921-32. doi: 10.1038/jcbfm.2014.41. Epub 2014 Mar 26.
6
A conserved virulence plasmidic region contributes to the virulence of the multiresistant Escherichia coli meningitis strain S286 belonging to phylogenetic group C.保守的毒力质粒区域有助于属于 C 群进化枝的多药耐药性大肠杆菌脑膜炎菌株 S286 的毒力。
PLoS One. 2013 Sep 26;8(9):e74423. doi: 10.1371/journal.pone.0074423. eCollection 2013.
7
Humanized mice, a new model to study the influence of drug treatment on neonatal sepsis.人源化小鼠,一种研究药物治疗对新生儿败血症影响的新模型。
Infect Immun. 2013 May;81(5):1520-31. doi: 10.1128/IAI.01235-12. Epub 2013 Feb 25.
8
Efficacy of bacteriophage therapy in experimental sepsis and meningitis caused by a clone O25b:H4-ST131 Escherichia coli strain producing CTX-M-15.噬菌体治疗产 CTX-M-15 型大肠埃希菌 O25b:H4-ST131 克隆引起的实验性脓毒症和脑膜炎的疗效。
Antimicrob Agents Chemother. 2012 Jul;56(7):3568-75. doi: 10.1128/AAC.06330-11. Epub 2012 Apr 9.
9
How can the microbiologist help in diagnosing neonatal sepsis?微生物学家如何协助诊断新生儿败血症?
Int J Pediatr. 2012;2012:120139. doi: 10.1155/2012/120139. Epub 2012 Jan 26.
10
Role of innate host defenses in susceptibility to early-onset neonatal sepsis.固有宿主防御在易感性中的作用 对早发性新生儿败血症。
Clin Perinatol. 2010 Jun;37(2):307-37. doi: 10.1016/j.clp.2010.04.001.